# Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816

> **NCT02554136** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HGP0918
- **DRUG:** HGP0816
- **DRUG:** HGP0918 + HGP0816

## Key facts

- **NCT ID:** NCT02554136
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02554136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02554136, "Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02554136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*